2022
Movement disorders, cerebral palsy and vaccination
LIBA, Zuzana, Josef KRAUS, Tomáš NEČAS, Jiri NECAS, Miloslav KLUGAR et. al.Základní údaje
Originální název
Movement disorders, cerebral palsy and vaccination
Autoři
LIBA, Zuzana (203 Česká republika), Josef KRAUS (203 Česká republika), Tomáš NEČAS (203 Česká republika), Jiri NECAS (203 Česká republika), Miloslav KLUGAR (203 Česká republika, domácí) a Pavel KRSEK (203 Česká republika, garant)
Vydání
European Journal of Paediatric Neurology, OXFORD, ELSEVIER SCI LTD, 2022, 1090-3798
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30210 Clinical neurology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.100
Kód RIV
RIV/00216224:14110/22:00125125
Organizační jednotka
Lékařská fakulta
UT WoS
000811339200024
Klíčová slova anglicky
Immunization; Vaccination; Movement disorders; Adverse events; Cerebral palsy
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 19. 7. 2022 10:42, Mgr. Tereza Miškechová
Anotace
V originále
This review focused on vaccination in children with movement disorders, including cerebral palsy and the movement disorders triggered by vaccination in children with and without neurological disabilities. The following clinical questions were addressed: 1) Can children with movement disorders be vaccinated? 2) Can vaccination trigger movement disorders in children without neurological disabilities? 3) Can vaccination trigger movement disorders in children with neurological disabilities? and 4) Is there any consensus of care concerning vaccination in children with movement disorders? Following the PRISMA reporting guidelines, 1096 records were identified and 34 relevant papers were included. No evidence that vaccinations are contraindicated for children with movement disorders was noticed. Several reports of neurological adverse events, including movement disorders in children without neurological disabilities after various types of vaccination, were found. The reporting rates were low, the causality was controversial, and patient outcomes were mostly favourable. There was limited (if any) evidence in our search that any vaccination leads to any movement disorder exacerbation. Finally, no generally accepted consensus or standards of care concerning vaccination in patients with movement disorders were found. In summary, we found few precautions for vaccination in this group of patients and concluded that general best practice guidelines for immunization should be followed. In addition, influenza and pneumococcal vaccines are recommended because they can reduce morbidity and mortality in individuals severely affected by movement restrictions.